Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Data-Driven Prognostication in Distal Medium Vessel Occlusions Using Explainable Machine Learning
7
Zitationen
11
Autoren
2024
Jahr
Abstract
BACKGROUND AND PURPOSE: Distal medium vessel occlusions (DMVOs) are estimated to cause acute ischemic stroke in 25%-40% of cases. Prognostic models can inform patient counseling and research by enabling outcome predictions. However, models designed specifically for DMVOs are lacking. MATERIALS AND METHODS: This retrospective study developed a machine learning model to predict 90-day unfavorable outcome (defined as an mRS score of 3-6) in 164 patients with primary DMVO. A model developed with the TabPFN algorithm used selected clinical, laboratory, imaging, and treatment data with the least absolute shrinkage and selection operator feature selection. Performance was evaluated via 5-repeat 5-fold cross-validation. Model discrimination and calibration were evaluated. SHapley Additive Explanations (SHAP) identified influential features. A Web application deployed the model for individualized predictions. RESULTS: The model achieved an area under the receiver operating characteristic curve of 0.815 (95% CI, 0.79-0.841) for predicting unfavorable outcome, demonstrating good discrimination, and a Brier score of 0.19 (95% CI, 0.177-0.202), demonstrating good calibration. SHAP analysis ranked admission NIHSS score, premorbid mRS, type of thrombectomy, modified TICI score, and history of malignancy as top predictors. The Web application enables individualized prognostication. CONCLUSIONS: Our machine learning model demonstrated good discrimination and calibration for predicting 90-day unfavorable outcomes in primary DMVO strokes. This study demonstrates the potential for personalized prognostic counseling and research to support precision medicine in stroke care and recovery.
Ähnliche Arbeiten
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
1993 · 12.192 Zit.
Correspondence - Tranexamic acid for traumatic brain injury
2005 · 11.734 Zit.
Tissue Plasminogen Activator for Acute Ischemic Stroke
1995 · 11.646 Zit.
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 · 11.555 Zit.
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 · 10.205 Zit.